HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry
2022 · Clinical Rheumatology · 15 citations
https://doi.org/10.1007/s10067-022-06490-8
S
Seraphina Kissling
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
85
Citations
6
h-index
3
i10-index
Seraphina Kissling is an academic researcher. The author has contributed to research in topics: Spondyloarthritis Studies and Treatments & Rheumatoid Arthritis Research and Therapies & Psoriasis: Treatment and Pathogenesis. The author has an h-index of 6, co-authored 14 publications.
ORCID: 0000-0003-0619-0012Papers by this author
worksAnaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry
2023 · Clinical Rheumatology · 6 citations
https://doi.org/10.1007/s10067-023-06662-0
Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort
2024 · Arthritis Research & Therapy · 5 citations
https://doi.org/10.1186/s13075-024-03302-z
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries
2025 · Arthritis Research & Therapy · 3 citations
https://doi.org/10.1186/s13075-025-03488-w
Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry
2023 · Arthritis Research & Therapy · 2 citations
https://doi.org/10.1186/s13075-023-03026-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat